依倍大剂量冲击疗法对化疗相关性贫血的疗效分析(3)
 |
| 第1页 |
参见附件(2331KB，3页)。
参考文献
[1] Rizzo JD,Lichtin AE,Woolf SH,et al.Use of epoetin in patients with cancer:evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.Clin Oncol,2002,20(19):4083-4107.
[2] Ariganello O,Mancuso A,Di Molfetta M,et al.A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.Lung Cancer,2004,46(1):119-124.
[3] Patton J,Kuzur M,Liqqett W,et al.Epoetin alfa 60 000 U once weekly followed by 120 000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.Oncologist,2004,9(1):90-96.
[4] Leyland-Jones B.BEST Investigators and Study Group.Breast cancer trial with erythropoietin terminated unexpectedly.Lancet Oncol,2003,4(8):459-460.
[5] Henke M,Laszig R,Rube C,et al.Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:randomised,double-blind,placebo-controlled trial.Lancet,2003,362(9392):1255-1260.
您现在查看是摘要介绍页，详见PDF附件(2331KB，3页)。